No insider purchase over the last 90 days. The latest was filed 22 Jul 2025.
This page follows insider dealings at Earth Science Tech, Inc. as filed with SEC (Form 4). Earth Science Tech, Inc. has had no insider filing for more than a year; the last one goes back to 22 July 2025.
For the fiscal year to 31 March 2026, the annual 10-K puts revenue at 35.7 m USD and net income at 3.6 m USD.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 96 declarations
Earth Science Tech, Inc. is a company focused on developing cannabis-based products, including nutritional supplements and health products. It is listed on NASDAQ under the symbol XNAS.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Mar 2026 | 35.7 m USD | 3.6 m USD | 0.01 USD | 10-K |
| Mar 2025 | 33.1 m USD | 3.3 m USD | 0.01 USD | 10-K |
| Mar 2024 | 12.0 m USD | 812,139 USD | 0.00 USD | 10-K |
| Mar 2023 | 48,537 USD | -365,405 USD | -0.00 USD | 10-K |
| Mar 2022 | n.d. | 3.2 m USD | n.d. | 10-K/A |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.